Screener
Immix Biopharma, Inc. IMMX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other assets | 20,418 | 20,418 |
| Deferred offering costs | 164,723 | 93,630 |
| Right-of-use asset, net | 927,728 | 966,917 |
| Property and equipment, net | 2,428,377 | 2,521,621 |
| Total assets | $95,816,057 | $104,840,341 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $10,414,266 | $9,971,207 |
Document
FAQ
- What is Immix Biopharma, Inc.'s PP&E (net)?
- Immix Biopharma, Inc. (IMMX) reported PP&E (net) of $2.43M in Q1 2026.
- How has Immix Biopharma, Inc.'s PP&E (net) changed year-over-year?
- Immix Biopharma, Inc.'s PP&E (net) increased by 14.3% year-over-year, from $2.12M to $2.43M.
- What is the long-term trend for Immix Biopharma, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s PP&E (net) has grown at a 221.3% compound annual growth rate (CAGR), from $7.36K to $2.52M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Immix Biopharma, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude